4//SEC Filing
Apelian David 4
Accession 0001140361-22-009254
CIK 0001305253other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 9:06 PM ET
Size
6.6 KB
Accession
0001140361-22-009254
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Common Stock
2022-03-11+6,000→ 16,000 total - Award
Stock Option (Right to Buy)
2022-03-11+12,000→ 12,000 totalExercise: $5.10Exp: 2032-03-10→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022.
- [F2]The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001546842
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 9:06 PM ET
- Size
- 6.6 KB